Realize Medical
Research Library · Independent literature review

Hepatobiliary & pancreatic (HPB): Does VR surgical planning improve patient outcomes?

5 Hepatobiliary & pancreatic (HPB) studies in the library address this question.

Hepatobiliary & pancreatic (HPB): Patient outcomesBar chart. Hepatobiliary & pancreatic (HPB): Patient outcomes. Retrospective studies 2, Reviews 1, Case reports & technical 2.RESEARCH LIBRARY · INDEPENDENT LITERATURE REVIEWHepatobiliary & pancreatic (HPB):Patient outcomes5 studies in the library, by study designRetrospective studies2Reviews1Case reports & technical2Positive findingMixedDescriptiveNo significant differenceRealize Medical Research Library · 631 studies · updated 2026-10-03

What the studies report

  • Positive finding
    “The total postoperative complications and hospitalization days in Group A were significantly less than those in Group B [14 (37.84%) vs 35 (60.34%), P = 0.032 and 12.05 ± 4.04 d vs 13.78 ± 4.13 d, P = 0.049, respectively].”

    Zhu 2022 · Retrospective cohort · n: 95 patients

  • Descriptive
    “In another case, the hologram enabled a safe Gliisonean pedicle approach for hepato-cellular carcinoma with a hilar anatomical anomaly.”

    Saito 2020 · Case series · n: 2 patients

  • Descriptive
    “All patients underwent successful resection of tumor under the guidance of 3D visualization and VR technology.”

    Zhu 2019 · Case series · n: 20 patients

How strong is the evidence?

Of 5 studies with a finding on this question: 1 report a positive finding, 2 descriptive, 2 no significant difference. These reflect what each study's authors report.

Study designs: 2 retrospective studies, 1 review and 2 case reports, case series and technical reports.

All 5 studies

Potential contribution of extended reality to safety in minimally invasive hepatectomy: a comparative study of laparoscopic and robotic approaches #

Naito S et al. · Journal of robotic surgery · 2026

Hepatobiliary & pancreatic (HPB) · Retrospective cohort · n: 102 patients

No significant difference
“Nevertheless, the estimated blood loss (median 150 mL vs. 100 mL, P = 0.054) and incidence of severe complications (6.4% vs. 0%, P = 0.094) did not differ significantly between the XR and non-XR groups.”

P = 0.054

DOIPubMed

Application value of mixed reality in hepatectomy for hepatocellular carcinoma #

Zhu LY et al. · World journal of gastrointestinal surgery · 2022

Hepatobiliary & pancreatic (HPB) · Retrospective cohort · n: 95 patients

Positive finding
“The total postoperative complications and hospitalization days in Group A were significantly less than those in Group B [14 (37.84%) vs 35 (60.34%), P = 0.032 and 12.05 ± 4.04 d vs 13.78 ± 4.13 d, P = 0.049, respectively].”

P = 0.032

DOIPubMedFree full text

Enhancing liver surgery and transplantation: the role of 3D printing and virtual reality #

Kasai M et al. · Artificial Intelligence Surgery · 2024

Hepatobiliary & pancreatic (HPB) · Narrative review

No difference reported
“Though safely implemented, AR failed to improve outcomes over standard techniques in this initial experience”

DOIFree full text

Intraoperative 3D Hologram Support With Mixed Reality Techniques in Liver Surgery #

Saito Y et al. · Annals of surgery · 2020

Hepatobiliary & pancreatic (HPB) · Case series · n: 2 patients

Descriptive
“In another case, the hologram enabled a safe Gliisonean pedicle approach for hepato-cellular carcinoma with a hilar anatomical anomaly.”

DOIPubMedFree full text

[Three-dimensional visual assessment and virtual reality study of centrally located hepatocellular carcinoma on the axis of blood vessels] #

Zhu W et al. · Zhonghua wai ke za zhi [Chinese journal of surgery] · 2019

Hepatobiliary & pancreatic (HPB) · Case series · n: 20 patients

Descriptive
“All patients underwent successful resection of tumor under the guidance of 3D visualization and VR technology.”

DOIPubMed

All hepatobiliary & pancreatic (hpb) studiesThis question across specialtiesBrowse the whole library

Summarises published research on VR/AR surgical planning across all platforms. Not product labelling. For Elucis indications see /elucis.

Intended for healthcare professionals.

Summaries and quotes describe each study's methods and the findings its authors report. They are not claims by Realize Medical and may contain errors: please read the original paper. Inclusion is not an endorsement of any product or use.